أخبار حالية

Instituto Bernabeu in Cartagena organises a medical event to address progress in treatment of uterine fibroids

  • 15-01-2020

Instituto Bernabeu in Cartagena is organising a scientific event to address progress in the treatment of uterine fibroids. The event will be held on Friday, 31st January in the graduation room at the Polytechnic University in Cartagena. This is just one of many scientific events that the clinic regularly organises at its Cartagena branch. The purpose of the events is to improve knowledge of reproductive health.

إقرأ المزيد

Ovarian rejuvenation: an opportunity for young patients suffering from premature menopause

  • 09-01-2020

Instituto Bernabeu is set to employ a new technique that helps women under 35 years of age to have children with their own ova. These women are otherwise compelled to turn to egg donation

إقرأ المزيد

Instituto Bernabeu travels to Portugal to address cases of poor responders and strategies for improving patients’ prognoses

  • 18-12-2019

Instituto Bernabeu’s participation in events held in Portugal on 4th and 5th December focused on poor responders and new strategies to help women achieve a pregnancy.

إقرأ المزيد

Instituto Bernabeu analyses if the number of ova obtained following stimulation has an impact on embryo quality

  • 16-12-2019

Does the number of oocytes obtained following ovarian puncture have an impact on embryo quality? This is the question that a team of researchers from the Embryology Departments at Instituto Bernabeu in Alicante and Albacete and the genetics laboratory at Biotech asked themselves as they proceeded to study the results obtained in almost 400 cycles of in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). The research work was presented in poster format at the Association for the Study of Reproduction Biology (ASEBIR) Congress, a gathering attended by leading global experts. The research was based on the relationship between the number of oocytes obtained following ovarian puncture and the results of IVF treatment.

إقرأ المزيد

Dr Rafael Bernabeu addresses the uterine factor as a cause of recurrent pregnancy loss at SEGO

  • 11-12-2019

Dr Rafael Bernabeu, Medical Director at Instituto Bernabeu, gave a speech within the framework of the ‘Review and updated handling of recurrent pregnancy loss’ course held in Madrid. The event was organised by the Spanish Society of Gynaecology and Obstetrics (SEGO).

إقرأ المزيد

Instituto Bernabeu investigates the factors that may affect successful embryo transfer

  • 10-12-2019

A team of researchers from the Embryology and Reproductive Medicine Units at Instituto Bernabeu in Madrid and Alicante have completed a study of the factors that may have the greatest impact on embryo transfer rates following a cycle of assisted reproduction. The research work was presented at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in late October in Cáceres.

إقرأ المزيد

An Instituto Bernabeu study analyses if ovarian stimulation can alter the risk of aneuploidies and mosaicism in embryos

  • 05-12-2019

The aim of research work performed by the Genetics and Molecular Biology Department at Instituto Bernabeu IBBiotech was to determine if there is a relationship between the ovarian stimulation process in cycles of in vitro fertilisation (IVF) and the aneuploidy and mosaicism rate in embryos. The conclusions were presented at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in October in Cáceres.

إقرأ المزيد

An Instituto Bernabeu research project demonstrates that the aneuploidy and mosaicism rates in blastocysts is similar in vitrified oocytes and fresh oocytes

  • 03-12-2019

Instituto Bernabeu gave an oral communication about oocyte vitrification at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres in October. Freezing is common practice during in vitro fertilisation (IVF) treatment because it increases the available number of blastocysts for analysis.

إقرأ المزيد

Instituto Bernabeu obtains the QH* Excellence in Healthcare accreditation

  • 28-11-2019

Instituto Bernabeu’s strive for excellence is clearly marked out in a meticulous work method and implementation of the most demanding healthcare and process quality controls with the aim of always achieving excellent results. The healthcare that patients are given is endorsed by certifications and accreditations awarded to the clinic by independent entities. Instituto Bernabeu Group has recently been awarded the QH* accreditation. It entails not only a renewal of the Quality Healthcare (QH) certification, but also an additional, higher level that has been driven by the ‘increase in the validity of certain certifications’, as highlighted by the Institute for Development and Integration of Health (IDIS), the accrediting organism.

إقرأ المزيد

Merck features Instituto Bernabeu research work on the efficiency of double stimulation as presented at the ESHRE congress

  • 27-11-2019

Instituto Bernabeu gave an oral communication at the European Society of Human Reproduction and Embryology (ESHRE) Congress entitled ‘The luteal phase of double ovarian stimulation treatment (DuoStim) provides higher oocyte and blastocyst yield in unselected infertile patients: a retrospective, same-patient, cohort study.’ This study is included in the articles that Merck has featured in its specialist journal focussing on fitting publications that is released following the scientific gathering focussing on fitting publications.

إقرأ المزيد

هل أنت بحاجة إلى مساعدة.
نحن نوجهك دون التزام.